Alpha-1 antitrypsin serum levels were found to be associated with some clinical outcomes related to SCD severity (Figure 6), with increased levels seen in patients that had two or more documented previous history of infection, occurrence of gallstones or received blood transfusion during follow-up. This evidence concerns the gene SERPINA1 and Schnyder corneal dystrophy.